|
Q4 2021
Filed on Jan 14, 2022
|
6,137
|
$44.65 - $81.34
$274K - $499K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
8,000
|
$14.95 - $39.46
$120K - $316K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
15,995
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
4,694
|
$30.49 - $48.49
$143K - $228K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
15,350
|
$13.36 - $14.25
$205K - $219K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
2,297
|
$84.53 - $113.64
$194K - $261K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
4,158
|
$41.2 - $73.6
$171K - $306K
|
|
Guggenheim Cr Allocation Fd
|
Q4 2021
Filed on Jan 14, 2022
|
11,573
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
12,085
|
$7.19 - $12.5
$86.9K - $151K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
11,200
|
$13.73 - $17.29
$154K - $194K
|
|
Blackrock 2022 Gbl Incm Opp
|
Q4 2021
Filed on Jan 14, 2022
|
23,900
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
10,000
|
$0.66 - $1.11
$6.6K - $11.1K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
24,515
|
$49.77 - $54.19
$1.22M - $1.33M
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
2,500
|
$37.34 - $90.5
$93.4K - $226K
|
|
Invivo Therapeutics Hldgs CO
|
Q4 2021
Filed on Jan 14, 2022
|
10,000
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
10,000
|
$0.38 - $0.68
$3.8K - $6.8K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
10,000
|
$5.14 - $7.71
$51.4K - $77.1K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
10,000
|
$2.7 - $4.5
$27K - $45K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
2,779
|
$77.56 - $90.65
$216K - $252K
|
|
Pieris Pharmaceuticals Inc
|
Q4 2021
Filed on Jan 14, 2022
|
12,500
|
N/A
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
11,230
|
$5.6 - $9.2
$62.9K - $103K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
2,501
|
$79.7 - $107.73
$199K - $269K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
9,200
|
$21.56 - $25.66
$198K - $236K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
20,000
|
$6.08 - $14.25
$122K - $285K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
4,741
|
$42.23 - $47.97
$200K - $227K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
38,215
|
$9.81 - $11.69
$375K - $447K
|
|
|
Q4 2021
Filed on Jan 14, 2022
|
9,730
|
$11.9 - $21.76
$116K - $212K
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Oct 19, 2021
|
4,080
|
N/A
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
124,123
|
N/A
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
29,595
|
N/A
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
15,944
|
$22.83 - $26.33
$364K - $420K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
27,405
|
$5.74 - $7.91
$157K - $217K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
10,440
|
$2.07 - $2.78
$21.6K - $29K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
14,003
|
N/A
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
363,809
|
$36.83 - $40.59
$13.4M - $14.8M
|
|
Maxim Integrated Prods Inc
|
Q3 2021
Filed on Oct 19, 2021
|
1,945
|
N/A
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
15,914
|
$22.14 - $27.45
$352K - $437K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
5,537
|
$32.41 - $40.57
$179K - $225K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
2,460
|
$128.64 - $184.79
$316K - $455K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
1,209
|
$116.17 - $194.55
$140K - $235K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
13,839
|
$21.52 - $21.61
$298K - $299K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
5,941
|
N/A
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
12,800
|
$8.01 - $10.21
$103K - $131K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
4,647
|
N/A
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
5,788
|
$39.22 - $58.02
$227K - $336K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
2,289
|
$105.26 - $152.99
$241K - $350K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
7,597
|
$25.02 - $30.0
$190K - $228K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
9,875
|
$17.08 - $28.65
$169K - $283K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
5,444
|
$46.26 - $59.94
$252K - $326K
|
|
|
Q3 2021
Filed on Oct 19, 2021
|
10,002
|
$25.34 - $25.8
$253K - $258K
|
|